Reston Hospital Center, a part of US-based healthcare network HCA Virginia, has opened an inpatient unit at its main hospital ...

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

Jones Trading initiated coverage on Mural Oncology (NASDAQ:MURA) with a Buy rating and a price target of $16.00. Currently trading at $3.95, the stock sits well below the broader analyst target range ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

Panel participants share an optimistic outlook for integrating new innovations, tacking community-level challenges, and more.

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

In a report released today, Roger Song from Jefferies maintained a Buy rating on Kura Oncology (KURA – Research Report), with a price target of ...

Researchers identified a 15-year shift toward surgical de-escalation in gynecologic oncology, marked by fewer surgical ...

Cambium Oncology is pleased to share that their lead drug candidate, ANT308, recently demonstrated outstanding single-agent efficacy and safety in preclinical ...